Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Bought by Hexagon Capital Partners LLC

Hexagon Capital Partners LLC increased its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 13.2% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 11,765 shares of the pharmacy operator’s stock after buying an additional 1,371 shares during the period. Hexagon Capital Partners LLC’s holdings in Walgreens Boots Alliance were worth $105,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of WBA. Iron Horse Wealth Management LLC grew its holdings in shares of Walgreens Boots Alliance by 162.5% during the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 1,300 shares during the last quarter. Pineridge Advisors LLC acquired a new position in Walgreens Boots Alliance during the 4th quarter valued at approximately $26,000. Blue Trust Inc. grew its stake in Walgreens Boots Alliance by 87.0% during the 2nd quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 1,081 shares during the last quarter. Continuum Advisory LLC increased its position in Walgreens Boots Alliance by 71.2% in the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 1,020 shares during the period. Finally, Strategic Investment Solutions Inc. IL bought a new stake in Walgreens Boots Alliance in the second quarter valued at $34,000. Institutional investors own 58.59% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on WBA shares. Evercore ISI dropped their price objective on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating on the stock in a report on Friday, June 28th. Truist Financial cut their price target on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a report on Monday. Bank of America reduced their price objective on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research report on Wednesday, September 4th. Morgan Stanley lowered their target price on Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating on the stock in a research report on Friday, June 28th. Finally, Royal Bank of Canada reduced their price target on Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research report on Tuesday, July 2nd. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $13.63.

Walgreens Boots Alliance Trading Up 1.3 %

Shares of NASDAQ WBA opened at $9.03 on Friday. The business’s 50-day simple moving average is $9.55 and its 200-day simple moving average is $13.61. Walgreens Boots Alliance, Inc. has a 52 week low of $8.22 and a 52 week high of $27.05. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.65 and a quick ratio of 0.31.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.